K.J. Harrison & Partners Inc Reduces Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

K.J. Harrison & Partners Inc trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.0% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 9,652 shares of the healthcare conglomerate’s stock after selling 509 shares during the period. K.J. Harrison & Partners Inc’s holdings in UnitedHealth Group were worth $5,081,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Iron Horse Wealth Management LLC lifted its stake in shares of UnitedHealth Group by 1.6% in the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after purchasing an additional 19 shares during the last quarter. Secure Asset Management LLC lifted its stake in shares of UnitedHealth Group by 0.8% during the 3rd quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock worth $1,238,000 after purchasing an additional 19 shares during the last quarter. Bensler LLC increased its position in shares of UnitedHealth Group by 0.3% during the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares in the last quarter. Texas Capital Bancshares Inc TX boosted its holdings in UnitedHealth Group by 1.1% in the third quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock worth $855,000 after acquiring an additional 19 shares in the last quarter. Finally, Tealwood Asset Management Inc. grew its holdings in shares of UnitedHealth Group by 0.4% during the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock valued at $2,626,000 after buying an additional 19 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on UNH. Oppenheimer reaffirmed an “outperform” rating and set a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price on the stock in a research report on Thursday, April 4th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. TD Cowen dropped their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research note on Wednesday, April 10th. Finally, Truist Financial reiterated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, EVP Erin Mcsweeney sold 1,236 shares of the stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares in the company, valued at $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Price Performance

UnitedHealth Group stock traded up $1.49 during midday trading on Friday, reaching $495.35. 2,608,554 shares of the company were exchanged, compared to its average volume of 4,508,195. The company has a market capitalization of $455.76 billion, a price-to-earnings ratio of 30.28, a P/E/G ratio of 1.41 and a beta of 0.54. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The firm’s 50-day simple moving average is $485.84 and its 200-day simple moving average is $514.21. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period in the previous year, the business earned $6.26 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio is 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.